2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$19.85+$0.02 (+0.08%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.1BMarket Cap
- 100.71%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$19.85+$0.02 (+0.08%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.83 | ||
Change | +$0.010 (+0.05%) | ||
Open | $20.02 | ||
High | $20.19 | ||
Low | $19.58 | ||
Previous Close | $19.82 | ||
Volume | 569,829 | ||
30-Day Average Volume | 747,373 | ||
1-Week Change | 1.23% | ||
1-Month Change | 5.37% | ||
1-Year Change | 100.71% | ||
3-Year Change | -24.89% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 53.6M | ||
Total Assets | $490.8M | ||
Market Cap | $1.1B | ||
Enterprise Value | $978.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$36.4M | ||
Free Cash Flow | -$20.0M | ||
EBIT | -$36.3M | ||
EBITDA | -$36.3M | ||
Net Working Capital | $386.8M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -24 | ||
PEG | -2 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue